MEDICATION INTELLIGENCE

Serial Number 86422645
602

Registration Progress

Application Filed
Oct 13, 2014
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

MEDICATION INTELLIGENCE

Basic Information

Serial Number
86422645
Filing Date
October 13, 2014
Abandonment Date
February 1, 2016
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Feb 24, 2016
Classes
044

Rights Holder

Millennium Health, LLC

16
Address
16981 VIA TAZON
San Diego, CA 92127

Ownership History

Millennium Health, LLC

Original Applicant
16
San Diego, CA

Legal Representation

Attorney
Michael K. Lindsey

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Feb 24, 2016 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Feb 24, 2016 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Jul 29, 2015 CNFR R FINAL REFUSAL WRITTEN Loading...
Jul 29, 2015 GNFR O FINAL REFUSAL E-MAILED Loading...
Jul 29, 2015 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jul 1, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 30, 2015 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 30, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 3, 2015 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 3, 2015 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 3, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 30, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 20, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 16, 2014 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Medical testing services for detection, diagnostic or treatment purposes marketed and sold to healthcare providers and insurers, namely, third-party testing of patient urine, blood and/or oral fluids; medical services, namely, medication monitoring and drug detection services to evaluate patient treatment plans and improve clinical outcomes and patient safety; drug use testing services, namely, testing patient urine, blood and/or oral fluid for medication or drug abuse and/or compliance with patient prescriptions; pharmacogenetic testing service for detection, diagnostic or treatment purposes that predict a patient's genetic predisposition to metabolizing medications; medical services, namely, providing medication therapy management based on predictive modeling of patient population data
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
044